Evidence map›Paper›PMID 30963336›Full record

ArticleClinical rheumatology2019

Brief report: the disability of chronic chikungunya arthritis.

J Kennedy Amaral, Joshua B Bilsborrow, Robert T Schoen

Open access · greenAbstract read
In one paragraph

Article in Clinical rheumatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Therapy for Chikungunya Arthritis: A Study of 133 Brazilian Patients.The American journal of tropical medicine and hygiene · 2023
    Article
  6. Review
  7. Classification of chikungunya cases: a proposal.Revista da Sociedade Brasileira de Medicina Tropical · 2020
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

J Kennedy AmaralDepartment of Infectious Diseases and Tropical Medicine, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Joshua B BilsborrowSection of Rheumatology, Allergy and Clinical Immunology, Yale University School of Medicine, New Haven, CT, USA.
Robert T SchoenSection of Rheumatology, Allergy and Clinical Immunology, Yale University School of Medicine, New Haven, CT, USA. robert.schoen@yale.edu.ORCID http://orcid.org/0000-0003-1844-8316
Yale University · USUniversidade Federal de Minas Gerais · BR

Funding

TRAINING PROGRAM IN INVESTIGATIVE RHEUMATOLOGYT32AR007107 · NIAMS · YALE UNIVERSITY · PI RICHARD J BUCALA · 1986 to 2026
$7.5M
NIAMS NIH HHS T32 AR007107
6 · The paper itself

Abstract

In 50% of patients, chikungunya fever (CHIKF) is followed by arthritic pain that is often chronic, painful, and disabling. To better define the spectrum of pain and disability in chronic CHIK arthritis (CCA), we evaluated 35 consecutive CCA patients seen in a Brazilian rheumatology clinic, using a pain Visual Analog Scale and the Health Assessment Questionnaire Disability Index. In our patients, pain and disability levels were of the same magnitude as are seen in other serious rheumatic diseases. The mean score for 19 patients with moderate disability was 1.42± 0.20 (median 1.37). The median HAQ-DI score for the entire group was 1.25. These findings underscore the morbidity imposed by CCA and the urgent need for improvements in management.

Indexed as

Disability EvaluationAdultAgedAged, 80 and overArthralgiaArthritisBrazilChikungunya FeverCross-Sectional StudiesFemaleHumansMaleMiddle AgedSeverity of Illness IndexYoung AdultChronic chikungunya arthritisDisabilityHealth Assessment Questionnaire Disability Index (HAQ-DI)Visual Analog Scale (VAS)

Identifiers

PMID30963336
PMCPMC7400963
OpenAlexW2940290171

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.